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A
 
BSTRACT
 
We report herein two cases of atopic cough in which
Basidiomycetes was detected from pharyngeal swabs
and in which gargling with amphotericin B was effica-
cious. One case is a 38-year-old woman and the other
is a 54-year-old woman. Both patients visited Ishikawa-
ken Saiseikai Kanazawa Hospital for the diagnosis and
treatment of isolated severe non-productive cough.
They did not have bronchial hyperresponsiveness to
methacholine or heightened bronchomotor tone.
Bronchodilator therapy was not effective for their
coughing. Basidiomycetes was isolated from pharyn-
geal swabs in both cases. Oral cleansing with ampho-
tericin B at 300 mg/day for approximately 2 weeks was
effective in treating the severe coughs. This is the first
report concerning the effectiveness of oral cleansing
with amphotericin B for atopic cough, in which Basidio-
mycetes was detected from pharyngeal swabs.
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I
 
NTRODUCTION
 
Cough is a common presenting symptom in general
practice and in the chest clinic. Patients presenting
with isolated chronic non-productive cough resistant to
antibiotics and the usual antitussive agents are frequently
referred to our clinic for diagnosis and treatment.
Gastroesophageal reflux-associated cough, post-nasal
drip-induced cough, angiotensin-converting enzyme
inhibitor- induced cough and cough variant asthma are
known as causes of non-productive cough.
 
1
 
 In addition,
we have proposed a bronchodilator-resistant non-
productive cough associated with global atopic constitu-
tion (abbreviated as atopic cough; AC) as another cause
of non-productive cough since 1992.
 
2–6
 
 The discovery of
causative antigens is recommended through environ-
mental surveys and fungal culture of sputum and pharyn-
geal swabs, especially when usual treatment fails to
improve the symptoms. We have reported atopic cough
patients caused by a hypersensitivity to 
 
Trichosporon asahii
 
,
 
7
 
Pichia guilliermondii
 
,
 
8
 
 
 
Streptomyces albus
 
9
 
 and Basi-
diomycetes, which has been corrected from 
 
Humicola fus-
coatra
 
 by Centraalbureau voor Schimmelcultures (CBS).
 
10
 
We have proposed that low-dose antifungal drugs
(itraconazole) would be an additional strategy in treating
severe atopic cough in which an allergic reaction to
fungal antigens is thought to be an etiology of eosin-
ophilic airway disorder.
 
8
 
 We now report herein two cases
of atopic cough in which Basidiomycetes was detected
from pharyngeal swabs and successfully treated with oral
cleansing with amphotericin B.
 
C
 
ASE
 
 
 
REPORTS
 
Case 1
 
A 38-year-old woman visited our hospital on 5 Novem-
ber 2002 because of non-productive cough with ticklish
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throat discomfort for 11 weeks. She was a housekeeper
and lived in a 15-year-old wooden house. She was a
non-smoker.
Physical examination revealed the following: her tem-
perature was 36.2
 
°
 
C. The conjunctivae were not anemic
or icteric. Cardiac examination was entirely within normal
limits. Auscultation of the lungs revealed no adventitious
breath sounds. There was no lymphadenopathy. The
patient’s white blood cell count was 7400 /
 
µ
 
L with a
differential of 75.0% segmented neutrophils, 17.8%
lymphocytes, 5.7% monocytes and 1.3% eosinophils.
C-Reactive protein was 0.0 mg/dL and the total serum
IgE level was 131 U/mL. Specific IgE antibody was nega-
tive against 
 
house-dust 6
 
, 
 
Dermatophagoides
 
, 
 
Candida
 
,
 
Alternalia, Penicilium
 
 and 
 
Aspergillus
 
. The following
laboratory findings were normal or negative: urinalysis,
stools for ova and parasites, serum electrolytes, total
protein and albumin, and bacterial, mycobacterial
and fungal cultures of sputum. Basidiomycetes was
cultured from a pharyngeal swab. The chest radiograph
showed normal findings. The immediate skin test for
Basidiomycetes was 10 
 
×
 
 8/14 
 
×
 
 14.
According to the standards of the American Thoracic
Society,
 
11
 
 a pulmonary function test using a Collins DS
system (Collins GS/Plus System; Braintree, MA, USA)
revealed forced vital capacity (FVC) 3.21 L (104.9% of
predicted value), forced expiratory volume in 1 s (FEV
 
1
 
)
2.77 L (89.6% of predicted value) and an FEV
 
1
 
/FVC ratio
of 86.3%. To assess bronchial reversibility, spirometry
was performed before and after 30 min inhalation of
300 
 
µ
 
g salbutamol sulfate. The bronchodilator therapy
did not significantly increase FEV
 
1
 
 (from 2.78 to 2.82 L),
indicating that that patient’s bronchomotor tone was not
increased.
Bronchial responsiveness to methacholine was meas-
ured according to the method of Cockcroft 
 
et al
 
.
 
12
 
 The
provocative concentration of methacholine required to
cause a 20% fall from baseline FEV
 
1
 
 (PC
 
20
 
) was 20 mg/mL.
The capsaicin cough threshold, measured by our pre-
viously reported method,
 
13,14
 
 was 0.98 
 
µ
 
mol/L. This
suggested cough reflex hypersensitivity. Bronchodilator
therapy, inhaled salbutamol sulfate 200 
 
µ
 
g on demand,
was entirely ineffective for this patient’s daily coughing.
These findings suggested that the diagnosis for this case
would be AC.
 
2–6
 
 She was treated with both the histamine
H
 
1
 
 receptor antagonist cetirizine hydrochloride (10 mg/
day) and beclomethasone dipropionate inhalation (BDP;
400 
 
µ
 
g/day) for approximately 10 days, but her coughing
was not sufficiently relieved on this treatment.
Basidiomycetes was isolated from a pharyngeal swab
sample from the patient cultured in sterile Petri dishes
containing Sabouraud’s agar medium supplemented
with antibiotics. For the preparation of an antigenic solu-
tion, Basidiomycetes was cultured on a medium (1% pep-
tone, 2% glucose) with 0.5% yeast extract for 20 days and
dried by acetone. The skin test to the fungal antigen
(polysaccharide) was performed by intradermal injection
of 0.02 mL of the solution (1 mg protein/mL). The
immediate-type skin reaction was positive for Basidio-
mycetes.
Based on these results, the patient was administered
oral cleansing with amphotericin B at 300 mg/day. Her
symptoms subsided within 2 weeks and her capsaicin
cough threshold increased from 0.98 to 3.92 
 
µ
 
mol/L.
Fungal culture of a pharyngeal swab obtained after oral
cleansing with amphotericin B did not yield any fungus.
 
Case 2
 
A 54-year-old woman visited our hospital on 9 Sep-
tember 2002 because of non-productive cough with
ticklish throat discomfort for 20 months. Physical exami-
nation revealed the following: temperature 36.8
 
°
 
C and
blood pressure 118/76 mmHg. The conjunctivae were
not anemic or icteric. Cardiac examination was entirely
within normal limits. Auscultation of the lungs revealed
no rales.
The white blood cell count was 5700 /
 
µ
 
L, with a
differential of 60.0% segmented neutrophils, 29.6%
lymphocytes, 8.5% monocytes and 1.5% eosinophils.
C-Reactive protein was 0.0 mg/dL and the total serum
IgE level was 72 U/mL. Specific IgE antibody titers were
negative against 
 
house-dust 6
 
 and 
 
Dermatophagoides
pteronyssinus
 
.
A pulmonary function test revealed FVC 3.53 L
(138.4% of predicted value), FEV
 
1
 
 2.94 L (137.4% of
predicted value) and an FEV
 
1
 
/FVC ratio of 83.3%. Inha-
lation of 300 
 
µ
 
g salbutamol sulfate did not significantly
increase FEV
 
1
 
 (from 2.94 to 3.01 L). The methacholine
PC
 
20
 
 was 20 mg/mL. The capsaicin cough threshold was
1.95 
 
µ
 
mol/L. This suggested cough reflex hypersensitivity.
Bronchodilator therapy (oral clenbuterol at 40 
 
µ
 
g/day and
inhaled salbutamol sulfate at 200 
 
µ
 
g on demand) was
entirely ineffective for this patient’s daily coughing.
Although these findings suggested that this case would
be diagnosed as AC, treatment with cetirizine hydro-
chloride (10 mg/day) or fluticasone propionate inhala-
tion (FP; 400 
 
µ
 
g/day) failed to relieve coughing.
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Basidiomycetes was isolated from a pharyngeal swab
culture. Based on these results, the patient was treated
with oral cleansing with fungizone syrup (300 mg/day).
Her symptoms subsided within 2 weeks and her capsaicin
cough threshold increased from 0.98 to 31.4 
 
µ
 
mol/L.
Fungal culture of a pharyngeal swab obtained from the
patient after oral cleansing with amphotericin B did not
yield any fungus.
 
D
 
ISCUSSION
 
We have described two patients who presented with
isolated chronic bronchodilator resistant non-productive
cough with an atopic constitution, eosinophilic tracheo-
bronchitis and airway cough receptor hypersensitivity
without bronchial hyperresponsiveness, which we have
termed ‘atopic cough’.
 
2–6
 
 Cough variant asthma
 
15
 
 (in
which the cough responds to bronchodilators) is recog-
nized as a precursor of typical asthma, but atopic cough
is not.
 
4
 
 Because atopic cough differs from cough variant
asthma with regard to both outcome and pathophysio-
logical features, we strongly recommend that AC should
be recognized as a new clinical entity presenting with
isolated chronic non-productive cough.
 
3
 
Based on our series of clinical studies on chronic
cough, the clinical features of AC are considered as
follows.
1. Chronic bronchodilator-resistant non-productive cough
with ‘tickle’ in the throat lasting for more than 8 weeks.
2. The absence of wheezing, dyspnea, hemoptysis or pleur-
isy and no adventitious lung sounds on examination.
3. The presence of one or more of the following global
atopic findings: past history and/or complication of aller-
gic diseases, except for bronchial asthma, family history
of allergic diseases, peripheral blood eosinophilia,
elevated total IgE level in serum, positive specific IgE
antibody to common aeroallergens and positive allergen
skin test.
4. The existence of eosinophils in hypertonic saline-induced
sputum and/or submucosa of biopsied trachea and/or
bronchi.
5. Normal FEV
 
1
 
, FVC and FEV
 
1
 
/FVC ratio.
6. No bronchial reversibility defined as a less than 5%
increase in FEV
 
1
 
 after inhalation of 300 mg salbutamol
following 250 mg aminophylline injection.
7. Bronchial responsiveness within normal limits.
8. Increased airway cough reflex sensitivity.
9. Complete relief of the cough on treatment with histamine
H
 
1
 
 receptor antagonists and/or corticosteroid therapy.
The discovery of causative antigens is important not
only in allergic eosinophilic pneumonia and allergic
bronchoplumonary fungal disease,
 
16,17
 
 but also in severe
AC in which the histamine H
 
1
 
 receptor antagonists and/
or corticosteroid therapy are insufficient for the treatment
of coughing.
We have reported patients with severe AC caused by a
hypersensitivity to 
 
T. asahii
 
,
 
7
 
 
 
P. guilliermondii
 
,
 
8
 
 
 
S. albus
 
9
 
and Basidiomycetes
 
.
 
10
 
We previously reported the first case of non-asthmatic
sputum eosinophilia caused by allergic reaction to Basid-
iomycetes antigen.
 
10
 
 In that case, the increase of eosino-
phils in the patient’s induced sputum was closely related
to the appearance of Basidiomycetes in his house, as
determined through a repeated environmental survey.
According to our experience of a case of AC caused
by 
 
P. guilliermondii
 
8
 
 in which an antifungal drug (itraco-
nazole, 150 mg/day for 2 weeks) was effective for the
treatment of severe cough, we have also reported
another two cases of AC caused by Basidiomycetes
antigen successfully treated with a low dose of antifungal
drugs (itraconazole, 150 mg/day for 2 weeks).
Gregory and Hirst reported a possible role for Basid-
iospores as air-borne allergens in 1952.
 
18
 
 The Basidio-
mycetes class, the most advanced of all fungi, has
between 20 000 and 25 000 species and has been
shown that members of this class are present in high
atmospheric concentrations in certain geographic
areas.
 
19,20
 
 In addition, it has been reported that between
42 and 68% of atopic asthmatics have demonstrated
positive type I wheal-and-flare skin reactivity to Basidio-
mycetes metabolic and somatic antigens.
 
21
 
 Basidio-
mycetes is important as an environmental fungus. We
have reported a case of cough variant asthma success-
fully treated with antifungal therapy and the cleansing of
the filter of the car air-conditioner.
 
22
 
Our speculation concerning the results in the present
report is that Basidiomycetes colonizing on the pharyn-
geal mucosa would act as an exacerbating antigen of AC
and the low dose of itraconazole could remove the
fungus from the pharynx, resulting in the successful
outcome. If this idea is correct, even oral cleansing with
antifungal drugs that are well-known to be effective in the
treatment of oral candidiasis
 
23
 
 and gastroesophageal
candidiasis
 
24
 
 may remove the fungus.
The recommended dosage for oral cleansing with
amphotericin B is 1 mL (100 mg) four times daily. The
suspension should be administered between meals to
permit prolonged contact with the oral lesions and be
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dropped directly on the tongue with the calibrated drop-
per. Patients should be directed to swish the medication
in the mouth for as long as reasonably possible before
swallowing.
In conclusion we have reported two cases of atopic
cough in which Basidiomycetes was detected from pharyn-
geal swab and treatment with oral cleansing with ampho-
tericin B successfully relieved the patients’ coughing. This
is the first report concerning the efficacy of oral cleansing
with amphotericin B for AC caused by an allergic reaction
to Basidiomycetes antigen. We propose that low-dose
antifungal drugs would be an additional strategy in treat-
ing AC in which an allergic reaction to antigens from
fungi colonizing in the airway is thought to be an exacer-
bating antigen of eosinophilic airway disorder.
 
25
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